ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Small Cell Lung Carcinoma
Colorectal Cancer
Squamous Cell Carcinoma of Head and Neck
Breast Cancer
Carcinoma

Lung Cancer trials near San Antonio, TX, USA:

A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

given with chemotherapy to adults with extensive-stage small cell lung cancer (ES-SCLC), a fast-growing type of lung cancer...

Enrolling
Small Cell Lung Cancer (SCLC)
Drug: Chemotherapy
Drug: PF-08634404

Phase 2, Phase 3

Pfizer
Pfizer

San Antonio, Texas, United States and 5 other locations

combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants.The main goals of this study are to:* E...

Enrolling
Limited Stage Small Cell Lung Cancer
Drug: Durvalumab
Drug: BMS-986489

Phase 2

SCRI Development Innovations

San Antonio, Texas, United States and 26 other locations

the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...

Active, not recruiting
Lung Cancer
Drug: Itacitinib
Drug: Osimertinib

Phase 1, Phase 2

Incyte
Incyte

San Antonio, Texas, United States and 30 other locations

with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung ...

Active, not recruiting
Metastatic Non Small Cell Lung Cancer
Drug: Pembrolizumab
Drug: Carboplatin

Phase 3

Daiichi Sankyo
Daiichi Sankyo

San Antonio, Texas, United States and 256 other locations

Non-Squamous Non-Small Cell Lung Cancer (NSCLC) remains a leading cause of cancer mortality worldwide, with poor survival ...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Carboplatin
Drug: Livmoniplimab

Phase 2, Phase 3

AbbVie
AbbVie

San Antonio, Texas, United States and 61 other locations

is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung...

Enrolling
Small-cell Lung Cancer
Neuroendocrine Cancer
Drug: BL-M14D1

Phase 1

Systimmune
Systimmune

San Antonio, Texas, United States and 15 other locations

A Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer after failur...

Enrolling
Non-Small Cell Lung Cancer
Drug: Pemetrexed
Drug: Carboplatin

Phase 2, Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

San Antonio, Texas, United States and 183 other locations

for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung cancers are due to muta...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Pemetrexed/Carboplatin
Drug: Pemetrexed/Cisplatin

Phase 3

AstraZeneca
AstraZeneca

San Antonio, Texas, United States and 152 other locations

of this study is to evaluate the efficacy of Pumitamig versus Pembrolizumab in participants with previously untreated advanced Non-Small Cell Lung...

Begins enrollment in 2 months
Non-Small Cell Lung Cancer (NSCLC)
Drug: Pumitamig
Drug: Pembrolizumab

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

San Antonio, Texas, United States and 249 other locations

This Phase 1/2, open-label, multicenter study is conducted in patients with previously treated selected solid tumors, including non-small ce ...

Enrolling
L-MYC and N-MYC Amplified Solid Tumors
Prostate Cancer
Drug: Oral MRT-2359

Phase 1, Phase 2

Monte Rosa Therapeutics

San Antonio, Texas, United States of America and 21 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems